Formerly dba TeraDiscoveries, Inc. and as Teraffinity, in 2004 the firm was renamed Cloud Pharmaceuticals Organized around utilizing cloud computing for the design and development of new drugs - the firm is employing proprietary artificial intelligence (AI) search of virtual space to find drug candidates that are qualified for development from the outset, enabling faster progress at lower cost and a higher success rate, even with elusive targets. The company is working on a wide variety of products, including therapies for cancer, diabetes, Crohn's disease, Autism, leukemia, fibrosis, Dengue fever, and sepsis.
